Connect with us

Health

Moderna begins testing omicron-matched COVID-19 shots in adults

Moderna has begun testing an omicron-specific COVID-19 booster in healthy adults.

The company announced Wednesday that the first participant had received a dose. Earlier this week, competitor Pfizer began a similar study of its own reformulated shots.

For more coronavirus news, visit our dedicated page.

It’s not clear whether global health authorities will order a change to the vaccine recipe in the wake of the hugely contagious omicron variant. The original vaccines still offer good protection against death and severe illness. Studies in the US and elsewhere show a booster dose strengthens that protection and improves the chances of avoiding even a milder infection.

Moderna pointed to a small study published in the New England Journal of Medicine on Wednesday that showed antibodies able to target omicron persisted for six months after a booster dose, although the levels were dropping.

Moderna’s new study will enroll about 600 people who already have received either two doses of the company’s original shots or two plus a booster dose. All the volunteers will receive a dose of the experimental omicron-matched version.

For the latest headlines, follow our Google News channel online or via the app.

Read more:

Moderna CEO says working on omicron-specific vaccine: Interview

Pfizer-BioNTech begin omicron COVID-19 vaccine trial: Statement

Valneva COVID-19 vaccine neutralizes omicron in early lab tests

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

Teen alcohol and nicotine use in Europe is up, WHO urges preventive measures

Substance use is on the rise among teenagers in Europe, Central Asia and Canada and girls now match or even exceed boys when it comes to smoking and drinking, the World Health Organization (WHO) said in a new report on Thursday.

Continue Reading

Health

Gender therapy review reveals devastating impacts on teens

A top Human Rights Council-appointed expert has welcomed the decision by all health authorities in the United Kingdom to halt the routine use of puberty-blockers offered to children as part of gender transition services, amid a sharp increase more widely in the number of teenage girls seeking such treatment and concerns that it might disrupt brain development.

Continue Reading

Health

New global campaign boosts lifesaving vaccines

Two UN agencies alongside the Bill and Melinda Gates Foundation and the global vaccine alliance Gavi launched on Wednesday a campaign to scale up programmes to save lives, marking the start of World Immunisation Week, celebrated annually during the last week of April.

Continue Reading

Trending